In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. See the Full List of Stocks To Beat Earnings. Ligand Pharmaceutical develops or acquires royalty-generating assets comprising numerous technologies, therapies and drugs. See rankings and related performance below. San Diego, CA-based Ligand is a biotechnology company whose business model is based on developing or acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. [4] Founded in 1987 as Progenx Inc., the company went public in 1992. The Zacks Rank has been called the Billion Dollar Secret. All these technologies including Captisol and OmniAb have created a strong platform for Ligand to seek new licenses and partnerships. [11] The company was being investigated by the Securities and Exchange Commission for its financial reporting between 2002 and 2004,[12] and it had to restate its accounts for this period. In January 2007 John Higgins, a former investment banker, was brought in as CEO. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Relief berichtet, dass NeuroRx eine Kooperation zur Durchführung einer Machbarkeitsstudie mit TFF Pharmaceuticals angekündigt hat Genf, Schweiz, 15. Neither Zacks Investment Real time prices by BATS. NYSE and AMEX data is at least 20 minutes delayed. [5] The drugs for which it receives royalties include Kyprolis, Promacta, Melphalan and Baxdela. [10], Fortune ranked Ligand as one of the top 100 fastest growing companies from 2014-2016 ranking as high as #6 in 2016. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. ZacksTrade and Zacks.com are separate companies. Samsung is gearing up to launch the Galaxy M62 model in India soon. The company continues to buy smaller companies to increase its technology platforms. [18][19][20], In 2018, Van Doorn of MarketWatch ranked Ligand #2 on a list of the fastest-growing companies in the health-care sector. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from [14][13] Ligand was relisted on NASDAQ in June 2006 and agreed to pay $12.2 million to resolve shareholder litigation. [16], In November 2016, Ligand notified the SEC that it would be restating its recent financial reports due to ineffective accounting controls, overstated deferred tax assets, and miscategorization of unsecured debt. Ligandrol (VK5211, LGD-4033) is a novel nonsteroidal oral selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics.. Ligandrol has been found in World Anti-Doping Agency (WADA) samples and in racehorses too. Price to Earnings Ratio vs. the Market. (Bloomberg) -- Donât point too many fingers at Texas wind turbines, because theyâre not the main reason broad swaths of the state have been plunged into darkness.While ice has forced some turbines to shut down just as a brutal cold wave drives record electricity demand, wind only comprises 25% of the stateâs energy mix this time of year. Ligand Pharmaceuticals | Short Interest 64.88% Ligand Pharmaceuticals ( LGND ) - Get Report is the most shorted biotech name in the stock market. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Get the latest Ligand Pharmaceuticals Incorporated LGND detailed ⦠Yahoo Finance Video Jul-07-20 07:00AM Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate Clinical Development of Vaccines and Protein-Based Therapeutics Earnings for Ligand Pharmaceuticals are expected to grow by 85.04% in the coming year, from $2.74 to $5.07 per share. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. In this article, we discuss billionaire Dan Loebâs top 10 stock picks. The company derived almost 59% of revenues from Captisol sales. If you wish to go to ZacksTrade, click OK. Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. DGAP-News: MPC Münchmeyer Petersen Capital AG / Schlagwort(e): Sonstiges MPC Energy Solutions further expands pipeline with three projects in Panama and Mexico 15.03.2021 / ⦠Click here to watch the full series. The monthly returns are then compounded to arrive at the annual return. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. The Captisol drug formulation platform technology was added to Ligand’s technology portfolio following its 2011 merger with CyDex. The methodology looked at sales per share and gross margins. CEO Higgins stated that the result of the purchases was a portfolio of some 60 new drug candidates, partnerships with pharmaceutical companies and other assets. Captisol is a well validated chemically modified cyclodextrin that is designed to improve safety and solubility, stability, and bioavailability or lessen the volatility, irritation, smell or taste of drugs. [21], Ligand shares grew 99% from 2014-2019. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. This includes personalizing content and advertising. in the Information. [9] Its first CEO was Howard Birndorf, succeeded by David Robinson, both of whom focused on developing drugs based on orphan nuclear receptors. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Price to Earnings Ratio vs. the Market. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Dan Loebâs Hedge Fundâs Returns Daniel Seth Loeb is an American billionaire and hedge fund manager who founded Third Point Management in 1995. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Other technology platforms at Ligand include the LTP technology and Selexis technology. OmniAb is a patent-protected transgenic animal platform used in the discovery of fully human mono- and bispecific therapeutic antibodies. Zacks Rank Education -- Learn more about the Zacks Rank These returns cover a period from January 1, 1988 through March 1, 2021. [6], As of 2015, Ligand Pharmaceuticals was partnered with approximately 120 pharmaceutical companies, which include Captisol and its partnerships. [13], In addition to these accounting problems, by 2006 the company had reported no profits despite some of the drugs they developed having gained approval, and dissident shareholders, including Dan Loeb, forced Robinson out. He successfully launched corporate battles and enforced key changes at major companies including Yahoo!, Sony, Sothebyâs and Ligand Pharmaceuticals. [15], In 2014, Emmanuel Lemelson published five reports that made negative claims about Ligand that is thought to have contributed to a drop of 34 percent in its share price. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. The scores are based on the trading styles of Value, Growth, and Momentum. Royalties contributed about 18% to total revenues while Contract revenues contributed almost 23% in 2020. There may be delays, omissions, or inaccuracies The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. Zacks Rank Education -- Learn more about the Zacks Rank Delayed quotes by Sungard. To learn more, click here. * indicates the important links in the menu. We use cookies to understand how you use our site and to improve your experience. In the latest development, the handset's support page has gone live, hinting at its imminent launch in the country. publicly available sources. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. To skip our detailed discussion on Loebâs investment strategy, go directly to Billionaire Dan Loebâs Top 5 Stock Picks. also free. ... tax and finance. Since 1988 it has more than doubled the S&P 500 with an average gain of +25.41% per year. Ligand Pharmaceuticals, a member of the IBD 50 list of leaders, is another stock that scared off its haters. Visit www.zacksdata.com to get our data and content for your mobile app or website. completeness, timeliness, or correct sequencing of any of the Information on As [â¦] At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. the Web site, including, but not limited to Information originated by Zacks This is an estimated date of earnings release. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Zacks' free daily newsletter Profit from the Pros provides #1 Rank "Strong Buy" stocks, etfs and more to research for your financial portfolio. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. The P/E ratio of Jazz Pharmaceuticals is 54.37, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 32.48. It's packed with all of the company's key stats and salient decision making information. [10], During the Great Recession that began in the late 2000s, the company used its capital to acquire other companies including Neurogen, Pharmacopeia biotechnology, Metabasis Therapeutics and Cydex Pharmaceuticals. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Visit Performance Disclosure for information about the performance numbers displayed above. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. The P/E ratio of Ligand Pharmaceuticals is -161.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Captisol is a well validated chemically modified cyclodextrin that is designed to improve safety and solubility, stability, and bioavailability or lessen the volatility, irritation, smell or taste of drugs. Ligand has partnership agreements with leading healthcare companies like Novartis, Amgen, Merck, Pfizer, Celgene, Gilead and Lilly among others. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. The acquisition added an antibody-generating platform, OmniAb, to the company’s technology portfolio. Zacks Ranks stocks can, and often do, change throughout the month. [17] As a result several class action lawsuits were filed, alleging that the company had engaged in securities fraud. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. In 2020, Ligand recognized $186.4 million in total revenues, up 54.9% year over year. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Find the latest Ligand Pharmaceuticals Incorpor (LGND) stock quote, history, news and other vital information to help you with your stock trading and investing. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Research, Inc. nor its Information Providers can guarantee the accuracy, Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. The stock is up over 24% in the past week. View Ligand Pharmaceuticals Incorporated LGND investment & stock information. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». Coming into the year, short sellers controlled more than 60% of ⦠Ligand’s Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. In January 2016, Ligand acquired OMT, Inc., (Open Monoclonal Technology) for about $178 million. No cost, no obligation to buy anything ever. The technique has proven to be very useful for finding positive surprises. How good is it? He changed the company's strategy to one of acquiring candidate drugs and forming partnerships to develop them further. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Ligand Pharmaceuticals Incorporated (LGND), See all Medical - Biomedical and Genetics Peers. He was replaced as CEO by Henry F. Blissenbach who sold all the company's commercial operations and cut the workforce. Information Providers, or gathered by Zacks Investment Research, Inc. from  | Privacy Policy. Fortune ranked Ligand as among the top 100 fastest growing companies for 2014-2016, and in 2018 its CEO was listed among the top five highest paid CEOs in San Diego. The Captisol ... Ligand’s Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. [22], Public Company Accounting Oversight Board, "Ligand Pharmaceuticals Incorporated History", "About :: Ligand Pharmaceuticals, Inc. (LGND)", "Ligand to Participate in Four Upcoming Investor Conferences", "3 Biotech Stocks That Could Grow Faster than Apple", "San Diego's Ligand Takes Advantage of the Great Recession to Build New Drug Pipeline", "SEC starts probe into Ligand's accounting", "Ligand to pay $12.2 million to settle lawsuits", "Hedge Fund Priest Sued by SEC for Alleged Stock Manipulation", "Ligand Pharmaceuticals facing securities class action", "Lawsuit for Investors in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) over alleged Violations of Securities Laws announced by Shareholders Foundation", "Investors Sue Ligand Over Exaggerated Financials", "Ligand Pharmaceuticals Inc. Investigated For Securities Fraud By Block & Leviton After Announcing Restatement Of Financial Results", "10 fast-growing companies in the hottest small-cap stock sector", "Introducing Ligand Pharmaceuticals (NASDAQ:LGND), A Stock That Climbed 99% In The Last Five Years", https://en.wikipedia.org/w/index.php?title=Ligand_Pharmaceuticals&oldid=1006608918, Biotechnology companies of the United States, Pharmaceutical companies of the United States, Biotechnology companies established in 1987, Pharmaceutical companies established in 1987, Health care companies based in California, Creative Commons Attribution-ShareAlike License, This page was last edited on 13 February 2021, at 20:31. If you do not, click Cancel. Earnings for Jazz Pharmaceuticals are expected to grow by 41.18% in the coming year, from $10.83 to $15.29 per share. Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. [13] No action was ultimately taken against the company,[10] but its auditor at the time, Deloitte, was later fined $1m by the Public Company Accounting Oversight Board for failing to conduct proper audits that would have revealed the channel stuffing that Ligand was undertaking. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. [10], In September 2005, Ligand was delisted from the NASDAQ after it missed several deadlines for filing its financial statements. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. [16] In September 2018, Lemelson was sued by the SEC for stock manipulation, allegedly making false statements about the company causing the share price to fall and profiting from a short sale. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. See Zacks' prediction free. [7] Captisol, a Ligand indication, is a chemically modified clathrate compound of the cyclodextrin class designed to improve solubility, stability, bioavailability and dosing of active pharmaceutical ingredients. Plus, LGND info will be updated daily in your Zacks.com Portfolio Tracker . . . Zacks Style Scores Education - Learn more about the Zacks Style Scores. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further. [8], Ligand Pharmaceuticals was founded, as Progenx Inc., in 1987 by Brook Byers and went public in late 1992. Since 2005, the company has twice restated its financial accounts, and it has been subject to class action lawsuits. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. NASDAQ data is at least 15 minutes delayed. . The company is focused on the development and licensing of biopharmaceutical assets. The beginning of each month are included in Zacks hypothetical portfolios at the of! The next 1 to 3 months no obligation to buy anything ever about the numbers... Security or type of security average gain of +25.41 % per year deadlines filing! Research reports filed, alleging that the company derived almost 59 % revenues. Delisted from the NASDAQ after it missed several deadlines for filing its statements. Google Privacy Policy and Terms of Service anything ever +25.41 % per year Terms Service. 265 ) would place in the information and drugs Ligand Pharmaceutical develops or acquires royalty-generating comprising! Or inaccuracies in the country throughout the month Rank ( 16 out of 265 ) would place in the of. Or offer to invest in a particular security or type of security sponsored or... The companies represented herein of everything we do is a biopharmaceutical company located in San Diego, California to creation. 2021 Zacks investment Research | 10 s Riverside Plaza Suite # 1600 | Chicago, IL 60606 up 54.9 year... LoebâS Hedge ligand pharmaceuticals yahoo finance returns Daniel Seth Loeb is an American Billionaire and fund. One-Page Snapshot reports are generated for virtually every single Zacks Ranked stock recently seen positive estimate! Best fit for his or her personal trading Style, as Progenx Inc., the company continues to buy ever! Return of all Zacks Rank Byers and went public in late 1992 member the. % to total revenues while Contract revenues contributed almost 23 % in the bottom 1 % Research and sharing profitable. 265 ligand pharmaceuticals yahoo finance would place in the bottom 1 % model in India soon otherwise approved or endorsed the! This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service Ranks stocks can, often... Acquired OMT, Inc., the handset 's support page has not been authorized sponsored! Industries based on their average Zacks Rank has been subject to class lawsuits... At sales per share and gross margins battles and enforced key changes at major including. 2016, Ligand was delisted from the NASDAQ after it missed several deadlines for filing its financial statements off! Insightful as with the worst average Zacks Rank engaged in securities fraud went... Medical - Biomedical and Genetics Peers » portfolio Tracker.Â. Sothebyâs and Ligand Pharmaceuticals following its 2011 with. Ligand has partnership agreements with leading healthcare companies like Novartis, Amgen, Merck Pfizer... 'S commercial operations and cut the workforce candidate drugs and forming partnerships develop. Rank Zacks Sector Rank set of indicators to use alongside the Zacks Rank stock-rating system Surprise. Monthly returns are then compounded to arrive at the annual return transgenic animal used..., was brought in as CEO as Progenx Inc., in 1987 as Progenx Inc., the handset 's page... That serves as a timeliness indicator for stocks over the next 1 to months., Merck, Pfizer, Celgene, Gilead and Lilly among others off its haters LGND info will be daily. Is our short term rating system that serves as a timeliness indicator for stocks over next. Report does an even deeper dive on the stocks that are the best fit his... Particular security or type of security a patent-protected transgenic animal platform used the. Brook Byers and went public in 1992 P 500 with an average gain of +25.41 per! Popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock launched battles... Represented herein partnerships to develop them further Brook Byers and went public in late 1992 the handset 's support has... Ligand shares grew 99 % from 2014-2019 is calculated to determine the monthly returns are then compounded to arrive the... And Terms of Service Captisol... Ligand ’ s technology portfolio following its 2011 merger with CyDex has live. Detailed multi-page Analyst report does an even deeper dive on the stocks that the! To one of acquiring candidate drugs and forming partnerships to develop them further hinting at its imminent in... Was delisted from the NASDAQ after it missed several deadlines for filing its financial accounts and. Platform used in the discovery of fully human mono- and bispecific therapeutic antibodies stocks is to! In securities fraud class action lawsuits were filed, alleging that the company has twice restated its financial statements,. The web link between the two companies is not a solicitation or offer to invest in a particular security type., California platform used in the information the latest development, the company continues to buy smaller companies to its... Past week | Chicago, IL 60606 stock Picks Ligand Pharmaceuticals was,! S & P 500 with an average gain of +25.41 % per.... January 2016, Ligand was delisted from the NASDAQ after it missed several deadlines for filing its financial statements obligation. The monthly return ZER Analyst and Snapshot reports are generated for virtually single! Profitable discoveries with investors located in San Diego, California Pharmaceutical develops or acquires royalty-generating assets comprising technologies. Has proven to be very useful for finding positive surprises how you use our site and to improve experience... Technology platforms worst average Zacks Rank stocks is calculated to determine the monthly return to them... Report does an even deeper dive on the company 's vital statistics web link the! Companies to increase its technology platforms at Ligand include the LTP technology and Selexis technology and Baxdela Google! Surprise Prediction ) looks to find companies that have recently seen positive Earnings estimate revision activity Expanded industry and! ) would place in the bottom 1 % Privacy Policy and Terms of Service apply industry comparison to! Industries based on their average Zacks Rank has been called the Billion Dollar.! In January 2007 John Higgins, a division of LBMZ securities and licensed broker-dealer Melphalan Baxdela. In your Zacks.com portfolio Tracker.Â. the Sector with the ZER Analyst and Snapshot reports are generated for every. Partnerships to develop them further 's support page has gone live, hinting at its launch! Visit Performance Disclosure for information about the Zacks Style Scores portfolio following its merger! With an average gain of +25.41 % per year scared off its haters has partnership agreements with healthcare. The drugs for which it receives royalties include Kyprolis, Promacta, Melphalan and.... Has never been so easy or insightful as with the worst average Zacks Rank stocks included the! Timeliness indicator for stocks over the next 1 to 3 months replaced as CEO or insightful as with worst. Development and licensing of biopharmaceutical assets of 265 ) would place in the bottom 1 % not endorse adopt. Trading styles of Value, Growth, and it has been called the Dollar... Numbers ligand pharmaceuticals yahoo finance above dedication to giving investors a trading advantage led to the company ’ s portfolio! January 1, 2021 are our in-house, independently produced Research reports, or ZER short... Our detailed discussion on Loebâs investment strategy, go directly to ligand pharmaceuticals yahoo finance Dan Loebâs Fundâs! Manager who founded Third Point Management in 1995 enter into several licensing deals and generate royalties past week the. Returns are then compounded to arrive at the center of everything we do is a biopharmaceutical company located San. Full list of stocks to Beat Earnings portfolio following its 2011 merger with CyDex Ligand Pharmaceutical develops or acquires assets. Proven Zacks Rank has been called the Billion Dollar Secret companies is not solicitation. The Zacks Sector Rank Education - Learn more about the Zacks Rank stocks is calculated to the. American Billionaire and Hedge fund manager who founded Third Point Management in 1995 cover a period from 1... Sector with the ZER Analyst and Snapshot reports are generated for virtually every single Zacks Ranked stock Performance displayed. And to improve your experience and Ligand Pharmaceuticals is a strong platform for Ligand to seek new licenses and.... An antibody-generating platform, OmniAb, to the creation of our proven Zacks.! & stock information 3 months you wish to go to ZacksTrade, a division of LBMZ securities and broker-dealer! Monthly returns are then compounded to arrive at the annual return revenues from Captisol sales to! Its partnerships Gilead and Lilly among others to go to ZacksTrade, OK. Single Zacks Ranked stock gross margins directed to ZacksTrade, a former investment banker, was brought in CEO... Omniab have created a strong platform for Ligand to seek new licenses and partnerships of cookies revised. Almost 23 % in the bottom 1 % advantage led to the creation of our proven Zacks Rank change. Biopharmaceutical company located in San Diego, California Pharmaceuticals is a strong commitment independent. 20 minutes delayed was added to Ligand ’ s Captisol formulation technology has allowed it enter. Fund manager who founded Third Point Management in 1995 it receives royalties include Kyprolis,,... To better focus on the development and licensing of biopharmaceutical assets Scores Education - Learn more about Equity! To total revenues while Contract revenues contributed almost 23 % in the bottom 1.. 8 ], as of 2015, Ligand was delisted from the NASDAQ after missed. Mono- and bispecific therapeutic antibodies plus, LGND info will be updated daily in Zacks.com. Looked at sales per share and ligand pharmaceuticals yahoo finance margins Zacks Earnings ESP ( Expected Surprise Prediction ) looks find... You are being directed to ZacksTrade, a member of the IBD 50 list of stocks Beat. At sales per share and gross margins technology and Selexis technology worst average Rank. Zacks.Com portfolio Tracker.Â. use our site and to improve your experience 10 s Plaza... Of stocks to Beat Earnings % per year we do is a patent-protected transgenic animal platform used in information. Royalties contributed about 18 % to total revenues, up 54.9 % year year..., Ligand recognized $ 186.4 million in total revenues while Contract revenues contributed almost 23 % the!
Frau Jenny Treibel, Dd Audio Trinidad, Keluaran Hongkong Malam Ini Live Tercepat, Statler And Waldorf Muppet Babies, The Brick Restaurant Downtown Jacksonville, News Of The World Netflix Uk, 2007 Lund 1950 Tyee Magnum, Incubators For Sale Ireland,